AllianceBernstein
Yahoo Finance • 25 days ago
Sterling Faces Hit From Seasonal Headwinds, Fiscal Uncertainty
Sterling’s recent recovery is unlikely to last due to seasonal headwinds and fiscal uncertainty, Convera said in a note. Continue Reading View Comments... Full story
Yahoo Finance • last month
Notification on acquisition of voting rights
Artea Bankas AB has received notification on acquisition of voting rights. Additional information: Tomas Varenbergas Head of Investment Management Division tomas.varenbergas@artea.lt , +370 610 44447 Attachment Notification-of-aquisi... Full story
Yahoo Finance • last month
Bioethanol Yeast Global Market Forecast Report 2025-2030 | Regulatory Harmonization Efforts to Accelerate Approval of Genetically Modified Yeast in Major Bioethanol Producing Regions
Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Bioethanol Yeast Market by Product (Active Yeast Products, Dried Yeast Products, Fresh Yeast Products), Formulation Type (Liquid Formulations, Solid Formulations), Technology, End-User Indus... Full story
Yahoo Finance • last month
Notice of the draft decisions on the agenda and general voting ballot for the Annual General Meeting of Shareholders of AUGA Group AB, a company undergoing restructuring, Convened on 29th August 2025
As previously announced, the Annual General Meeting of Shareholders of AUGA group, AB, a company undergoing restructuring (legal entity code 126264360, registered office at Konstitucijos Ave. 21C, Vilnius, hereinafter – the “Company”) is c... Full story
Yahoo Finance • last month
2025 m. 6 mėn.: solidūs rezultatai ir nuoseklus strategijos įgyvendinimas, pažymėtas Baltijos šalyse didžiausio 313,7 MW Kelmės vėjo parko komercinės veiklos pradžia. 2025 m. Koreguoto EBITDA ir Investicijų prognozė išlieka nepakitusi
AB „Ignitis grupė“ skelbia 2025 m. 6 mėn. tarpinį pranešimą, kuris pridėtas prie šios publikacijos. Finansiniai rezultatai Mūsų 2025 m. 6 mėn. Koreguotas EBITDA siekė 300,8 mln. Eur (+3,8 proc., palyginti su 2024 m. 6 mėn.). Augimą daugi... Full story
Yahoo Finance • 2 months ago
New AB Akola Group Investor Calendar for 2025/2026
AB Akola Group updates its 2025/2026 Investor Calendar, rescheduling the Investor Webinar from August 22 to August 21, 2025. A list of key information disclosure dates in 2025/2026: August 20, 2025Interim unaudited report for 12 months o... Full story
Yahoo Finance • 2 months ago
AB Science announces the successful completion of a 2.55 million euros private placement
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.55 MILLION PRIVATE PLACEMENT Paris, August 4, 2025, 8am CET AB Science S.A. (the “Company” or “AB Science”, Euronext – FR0010557264 – AB) announces today the succes... Full story
Yahoo Finance • 2 months ago
AB Science annonce le succès d’un placement privé d’environ 2,55 millions d’euros
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE D’ENVIRON 2,55 MILLIONS D’EUROS Paris, 4 août 2025, 8h AB Science S.A. (la “Société” ou “AB Science”, Euronext – FR0010557264 – AB) annonce aujourd'hui le succès d'u... Full story
Yahoo Finance • 2 months ago
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939... Full story
Yahoo Finance • 2 months ago
AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA
COMMUNIQUÉ DE PRESSE AB SCIENCE A RECU L’APPROBATION REGLEMENTAIRE DE PAYS EUROPEENS POUR INITIER LA TROISIEME ETAPE DE LA PHASE I/II VISANT A COMBINER SA MOLÉCULE AB8939 AVEC LE VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË... Full story
Yahoo Finance • 2 months ago
Everyone's Watching Nvidia -- but This AI Supplier Is the Real Power Player
Key Points Nvidia has played a pioneering role in the proliferation of AI, but it wouldn't have been possible without this company. Nvidia, along with many other chip designers and consumer electronics companies, relies on the manufacturi... Full story
Yahoo Finance • 2 months ago
AB Science gets approval to start ALS drug confirmatory trial in Europe
PARIS - AB Science SA (Euronext:AB), a pharmaceutical company with a market capitalization of $4.62 billion and an impressive InvestingPro Financial Health Score of "GREAT," has received authorization from several European countries to ini... Full story
Yahoo Finance • 2 months ago
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: * Nokia Oyj (NOK [https://seekingalpha.com/symbol/NOK]) * Blackstone (BX [https://seekingalpha.com/symbol/BX]) * American Airlines Group (AAL [https://seekingalpha.com/sym... Full story
Yahoo Finance • 3 months ago
AllianceBernstein assets under management rise to $829 billion in June
NEW YORK - AllianceBernstein L.P. (NYSE:AB) reported Thursday that its preliminary assets under management increased to $829 billion at the end of June 2025, up 3% from $803 billion in May. The company, currently valued at $4.62 billion, h... Full story
Yahoo Finance • 3 months ago
AB Announces June 30, 2025 Assets Under Management
NASHVILLE, Tenn., July 10, 2025 /PRNewswire/ -- AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") (NYSE: AB) today announced that preliminary assets under management increased to $829 billion during June 2025... Full story
Yahoo Finance • 3 months ago
Goldman Sachs turns bullish on select asset managers, upgrades BEN, AMG
Investing.com -- Goldman Sachs has turned bullish on select traditional asset managers, upgrading Franklin Resources (NYSE:BEN) and Affiliated Managers Group (NYSE:AMG) to Buy, citing improving organic growth prospects and compelling valua... Full story
Yahoo Finance • 3 months ago
Goldman Sachs downgrades AllianceBernstein stock on slowing growth
Investing.com - Goldman Sachs downgraded AllianceBernstein (NYSE:AB) stock rating to Neutral from Buy on Thursday, maintaining a price target of $40.00, which is approximately in line with the current share price of $40.90. The stock is tr... Full story
Yahoo Finance • 3 months ago
EQH stock hits all-time high, reaching 56.01 USD
AXA Equitable Holdings Inc (NYSE:EQH) stock reached an all-time high of $56.01, marking a significant milestone for the $17 billion market cap company. With a solid P/E ratio of 14.7 and an impressive revenue growth of 45% last year, the... Full story
Yahoo Finance • 3 months ago
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer's disease
PRESS RELEASE NEW PEER-REVIEWED DATA PROVIDE STRONG EVIDENCE SUPPORTING MASITINIB’S POTENTIAL FOR THE TREA™ENT OF ALZHEIMER’S DISEASE THROUGH A DUAL MECHANISM OF COGNITIVE ENHANCEMENT AND NEUROPROTECTION THIS PUBLICATION CORROBORATES NEW... Full story
Yahoo Finance • 3 months ago
AllianceBernstein Launches AB Emerging Markets Opportunities ETF
NASHVILLE, Tenn., June 18, 2025 /PRNewswire/ -- AllianceBernstein Holding L.P. (NYSE: AB) and AllianceBernstein L.P. ("AB"), a leading global investment management firm, announced today the launch of AB Emerging Markets Opportunities ETF (... Full story
